Tecogen Inc. (TGEN) Stock Price & Analysis
Tecogen Inc. (TGEN) fell 5.29% to USD 3.22 as of July 25, 2026 at 05:33 UTC, according to Nexqual real-time market data.
TGEN last closed at USD 3.4; the session ranged USD 3.15–3.38 on volume of 336,988 shares. Market capitalization is $96.34M, with a 52-week range of USD 1.94–12.07 (ASE). Source: Nexqual, July 25, 2026 at 05:33 UTC.
Key Statistics (as of July 25, 2026 at 05:33 UTC)
| Price | USD 3.22 |
|---|---|
| Change | ▼ 5.29% (down) |
| Previous Close | USD 3.4 |
| Open | USD 3.38 |
| Day Range | USD 3.15 – 3.38 |
| 52-Week Range | USD 1.94 – 12.07 |
| Volume | 336,988 shares |
| Market Cap | $96.34M |
| Exchange | ASE |
Technical Analysis (TGEN)
Nexqual's technical model rates TGEN "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 25.84 (oversold) |
| vs SMA50 | Below (USD 5.21) |
| MACD | -0.52 (negative) |
Analyst Ratings (TGEN)
Wall Street analysts rate TGEN "Strong Buy" based on 3 analysts, with a mean price target of USD 8.83 (range USD 7.5–10), per Nexqual as of July 25, 2026 at 05:33 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 8.83 |
| High Target | USD 10 |
| Low Target | USD 7.5 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (TGEN)
| Next Earnings Date | 2026-08-12 |
|---|---|
| EPS Estimate | USD -0.08 |
| Revenue Estimate | $5.85M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.1 vs est -0.1 ▲ beat |
| 2025-09-30 | USD -0.07 vs est -0.05 ▼ miss |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Financials & Fundamentals (TGEN)
| Total Revenue | $26.13M |
|---|---|
| Revenue Growth (YoY) | -12.90% |
| Gross Margin | +35.18% |
| Operating Margin | -33.67% |
| Profit Margin | -37.16% |
| ROE | -66.83% |
| Debt / Equity | 14.61 |
| Current Ratio | 3.02 |
| Total Cash | $9.33M |
| Total Debt | $2.86M |
| Free Cash Flow | $-11.05M |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Financial Health Score (TGEN)
Nexqual rates Tecogen Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:33 UTC.
| Growth | Critical — Revenue -13% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $9M cash vs $3M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Critical — ROE -67%, ROA -16.9% |
Ownership (TGEN)
| Insider Ownership | +39.97% |
|---|---|
| Institutional Ownership | +33.65% |
| Shares Outstanding | 29.92M |
| Float | 16.56M |
| Short % of Float | +5.38% |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Leadership (TGEN)
Tecogen Inc. is led by Abinand Rangesh (age 39), CEO & Director, per Nexqual as of July 25, 2026 at 05:33 UTC.
| CEO & Director | Abinand Rangesh (age 39) |
|---|---|
| President & COO | Robert A. Panora (age 71) |
| CFO, Treasurer & Chief Accounting Officer | Roger P. Deschenes (age 66) |
| Vice President of Business Development | Stephen Lafaille (age 37) |
Major Backers & Investors (TGEN)
Notable institutional backers of Tecogen Inc. include Fidelity, Bard Associates Inc., Clear Harbor Asset Management, LLC, according to Nexqual as of July 25, 2026 at 05:33 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 3.57% |
| Bard Associates Inc. | 2.75% |
| Clear Harbor Asset Management, LLC | 2.6% |
| Portolan Capital Management, LLC | 1.78% |
| Herald Investment Management Ltd | 1.68% |
| Arosa Capital Management LP | 1.4% |
| Palisades Investment Partners, LLC | 1.34% |
| UBS Group AG | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.08% |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
From Tecogen Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Tecogen Inc., together with its subsidiaries, designs, manufactures, markets, and maintains cogeneration products for multi-family residential, commercial, recreational, and industrial use in the United States.
- It operates in three segments: Products, Services, and Energy Production.
- Its Services segment provides operations and maintenance services; and parts sales, and installation services.
- The Energy Production segment installs, operates, and maintains distributed own generation electricity systems and sells the energy generated by such systems in the form of electricity, heat, hot water, and cooling to its customers under long-term energy sales agreements.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.46 | ▲ 0% |
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.13 | ▲ 0% |
| NGEN | NervGen Pharma Corp. | USD 1.63 | ▼ 5.23% |
| GNTA | Genenta Science S.p.A. | USD 1.59 | ▼ 3.05% |
| VRA | Vera Bradley, Inc. | USD 3.69 | ▼ 4.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:33 UTC. This page is informational and not investment advice.